These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1010710)

  • 21. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
    Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H; Dufresne RL; Weber SS; McCalley-Whitters M
    Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine for the treatment of tardive dyskinesia.
    Almeida OP
    J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
    Grant MJ; Baldessarini RJ
    Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895
    [No Abstract]   [Full Text] [Related]  

  • 24. Pisa syndrome: acute and tardive forms.
    Praharaj SK; Arora M
    South Med J; 2007 Aug; 100(8):853-4. PubMed ID: 17713320
    [No Abstract]   [Full Text] [Related]  

  • 25. Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.
    Chouinard G; Boisvert D; Bradwejn J
    Can Med Assoc J; 1982 Apr; 126(7):821-2, 827. PubMed ID: 6122496
    [No Abstract]   [Full Text] [Related]  

  • 26. Tardive dyskinesia: are first signs reversible?
    Quitkin F; Rifkin A; Gochfeld L; Klein DF
    Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 29. Metoclopramide and haloperidol in tardive dyskinesia.
    Bateman DN; Dutta DK; McClelland HA; Rawlins MD
    Br J Psychiatry; 1979 Dec; 135():505-8. PubMed ID: 43755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia with low-dose, short-term neuroleptic therapy.
    Stimmel GL
    Am J Hosp Pharm; 1976 Sep; 33(9):961-3. PubMed ID: 984060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia in young adults.
    Tarsy D; Granacher R; Bralower M
    Am J Psychiatry; 1977 Sep; 134(9):1032-4. PubMed ID: 409302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1976 Nov; 50(3):237-40. PubMed ID: 826968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease.
    Mizrahi EM; Holtzman D; Tharp B
    Arch Neurol; 1980 Dec; 37(12):780. PubMed ID: 6934716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia in Tourette syndrome.
    Golden GS
    Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reserpine treatment of comorbid Tourette's disorder and tardive dystonia.
    Rojas VM; Davies RK
    J Clin Psychiatry; 1999 Oct; 60(10):709-10. PubMed ID: 10549693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.